Procter & Gamble earnings beat estimates as sales grow 7%
Procter & Gamble reported quarterly earnings and revenue that topped Wall Street’s expectations.
The organization reiterated its full-year forecast for earnings and sales.
Procter & Gamble on Friday reported quarterlyĀ earningsĀ and revenue that topped analysts’ expectations, as volume for its products grew for the first time in a year.
Here’s what the firm reported compared with what Wall Street was expecting, based on a survey of analysts by LSEG:
Revenue: $21.24 billion vs. $20.5 billion expected
P&G reported fiscal third-quarter net income attributable to the enterprise of $3.93 billion, or $1.63 per share, up from $3.78 billion, or $1.54 per share, a year earlier.
Net salesĀ rose 7% to $21.24 billion. Organic sales, which strip out acquisitions, divestitures and currency, increased 3%. Furthermore, experts in wall street note the continued relevance.
P&G’s volume increased 2%, marking the first time in a year that it reported growing volume across the corporation. The metric excludes pricing, which makes it a more accurate reflection of demand than sales. Like many consumer companies, P&G has seen demand for its products shrink as shoppers try to spend less and stretch their laundry detergent and shampoo further.
P&G’s beauty division, which includes Olay, Head & Shoulders and Pantene, was the star of the quarter, with 5% volume growth. P&G stated it saw volume increases across its personal care, skin care and hair care categories.
The baby, feminine and family care segment saw volume boost 3%. The business saw higher demand for its diapers and family care products, which includes Bounty paper towels and Charmin toilet paper.
P&G’In the quarter, s fabric and home care division reported that volume rose 2%, fueled by higher North American demand for its Tide detergent.
Grooming and health care were the two laggards of the portfolio. The grooming segment, which includes Gillette and Venus products, saw volume fall 2%. Health care, which houses Oral-B and Vicks, also reported that volume declined 2%.
The corporation reiterated its full-year forecast of sales growth between 1% and 5% and net earnings per share growth in the range of 1% to 6%.
“We’re increasing investments to accelerate momentum with consumers despite the challenging geopolitical and economic environment, while still maintaining our guidance ranges for the fiscal year,” CEO Shailesh Jejurikar remarked in a statement. This also touches on aspects of earnings report.